To test whether rJEV/ZIKVP6-740 can induce neutralizing antibodies and provide protection against ZIKV infection, we conducted two experiments: one to assess the neutralizing antibody response and the other to evaluate protective efficacy in weanling IFNAR−/− mice (Figure 5A). This evidence concerns the gene IFNAR1 and Zika virus infectious disease.